Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (18)

2024

  1. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry

    European Journal of Pediatrics, Vol. 183, Núm. 8, pp. 3567-3578

  2. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry

    United European Gastroenterology Journal, Vol. 12, Núm. 5, pp. 585-595

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Corrigendum to “Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry” [Digestive and Liver Disease Volume 55, Issue 3, March 2023, Pages 350–359] (Digestive and Liver Disease (2023) 55(3) (350–359), (S1590865822007289), (10.1016/j.dld.2022.09.020))

    Digestive and Liver Disease

  3. Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry

    Digestive and Liver Disease, Vol. 55, Núm. 3, pp. 350-359

  4. Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress

    Frontiers in immunology, Vol. 14, pp. 1185517

  5. Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk

    Immunity and Ageing, Vol. 20, Núm. 1

2022

  1. Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry

    United European Gastroenterology Journal, Vol. 10, Núm. 5, pp. 507-517

  2. EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe

    Therapeutic Advances in Gastroenterology, Vol. 15

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. BRIP1, a gene potentially implicated in familial colorectal cancer type X

    Cancer Prevention Research, Vol. 14, Núm. 2, pp. 185-193

  2. HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients

    Frontiers in Immunology, Vol. 12

2018

  1. Overexpression of insulin receptor substrate-4 is correlated with clinical staging in colorectal cancer patients

    Journal of Molecular Histology, Vol. 49, Núm. 1, pp. 39-49

2017

  1. A novel community driven software for functional enrichment analysis of extracellular vesicles data

    Journal of Extracellular Vesicles, Vol. 6, Núm. 1

2014

  1. The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: Serial observations in 37 patients

    Inflammatory Bowel Diseases, Vol. 20, Núm. 4, pp. 695-702

2010

  1. Impacto de los niveles preoperatorios de hemoglobina y albúmina en la supervivencia del carcinoma de páncreas

    Revista Espanola de Enfermedades Digestivas, Vol. 102, Núm. 11, pp. 631-636

  2. Role of intratumoral lymphatic vessels in the lymph node dissemination of laryngopharyngeal squamous cell carcinoma

    Head and Neck, Vol. 32, Núm. 6, pp. 757-762

2009

  1. Polymorphisms in the hypoxia inducible factor 1-α and the impact on the prognosis of early stages of oral cancer

    Annals of Surgical Oncology, Vol. 16, Núm. 8, pp. 2351-2358